Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Two-Way Crossover Evaluation of the Bioequivalence Between Two Oral Formulations of Diphenhydramine: ULTRATAB Tablet Versus KAPSEALS Capsule

NCT00662337 is registered in ClinicalTrials.gov with Johnson & Johnson Consumer and Personal Products Worldwide as lead sponsor.

NCT NCT00662337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00662337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Two-Way Crossover Evaluation of the Bioequivalence Between Two Oral Formulations of Diphenhydramine: ULTRATAB Tablet Versus KAPSEALS Capsule
Lead sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2006
Completion date
November 30, 2006
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nasal congestion